Endothelial cell growth factor and heparin regulate collagen gene expression in keloid fibroblasts

Biochem J. 1991 Sep 15;278 ( Pt 3)(Pt 3):863-9. doi: 10.1042/bj2780863.

Abstract

Keloids are benign cutaneous tumours characterized by excess deposition of collagen, specifically type I collagen. We report here that collagen biosynthesis, as measured by hydroxyproline synthesis, was markedly inhibited by 65-80% by the combination of endothelial cell growth factor (ECGF) supplement and heparin in keloid fibroblast cultures. Fibroblast cultures that were incubated with ECGF alone also demonstrated a measurable decrease of approx. 50% in collagen synthesis compared with control cultures. The inhibition of collagen synthesis was related to the down-regulation of collagen gene expression. Quantitative measurements of mRNA-cDNA hybrids revealed that the gene expression of collagen type I was decreased by more than 80% by heparin and ECGF. Markedly diminished levels of mRNA encoding collagen type I were also observed in cultures incubated with ECGF alone. The results show that ECGF and heparin elicit a negative regulatory effect on collagen production, and that this inhibition is due largely to the down-regulation of the pro-alpha 1(I) of type I collagen gene. Furthermore, ECGF has a potent suppressive effect, and heparin provides an additive effect to this inhibitory phenomenon.

MeSH terms

  • Adult
  • Blotting, Northern
  • Cells, Cultured
  • Collagen / biosynthesis
  • Collagen / genetics*
  • DNA Probes
  • Endothelial Growth Factors / pharmacology*
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fluorescent Antibody Technique
  • Gene Expression Regulation / drug effects*
  • Heparin / pharmacology*
  • Humans
  • Hydroxyproline / biosynthesis
  • Keloid / metabolism*
  • RNA, Messenger / analysis
  • RNA, Messenger / metabolism

Substances

  • DNA Probes
  • Endothelial Growth Factors
  • RNA, Messenger
  • Heparin
  • Collagen
  • Hydroxyproline